Laboratory capacity and capability

Tools for public health
This image describes the targets of the EULabCap scheme

ECDC aim to strengthen the capability and capacity of the EU public health microbiology system to provide the timely and reliable information that underpins infectious threat detection, assessment and surveillance at Member State and EU level for effective prevention and control of infectious diseases.

EU Laboratory Capability Monitoring System (EULabCap)

The primary goal of the EU laboratory Capability Monitoring System is to assess public health microbiology vulnerabilities, identifying priorities and monitoring the impact of capacity building activities and system reforms at national and EU level on essential public health functions provided by microbiology laboratories.

The tool combines 60 indicators (grouped in 12 targets each comprising 5 indicators) on three public health dimensions:

  • Dimension 1 - primary diagnostic testing (targets1.1-1.4)
  • Dimension 2 - national microbiology reference laboratory (NRL) services (targets 2.1-2.4)
  • Dimension 3 - surveillance and epidemic response support (targets 3.1-3.4)

Aggregated indices have been calculated for each target and dimension as the average of component indicator scores, adjusting all index values on a scale of 0—10.

Contact us at:

EULabCap maps



Increasing number of cases and outbreaks caused by Candida auris in the EU/EEA, 2020 to 2021

Nov 2022 | Eurosurveillance | 27

Kohlenberg A., Monnet D.L., Plachouras D., Willinger B., Lagrou K., Philipova I., Budimir A., Marcou M., Hadjihannas L., Barekova L., Kubele J., Arendrup M.C., Dotsenko L., Lindholm L., Lyytikainen O., Desnos-Ollivier M., Dromer F., Hecht J., Kurzai O., Politi L., Vrioni G., Hajdu A., Kiss K., Gudlaugsson O., Frost S., Sabbatucci M., Voita I., Walser-Domjan E., Valinteliene R., Mzabi A., Perrin M., Abela R., Notermans D.W., Verweij P.E., Kacelnik O., Sare M., Dzierzanowska-Fangrat K., Lebre A., Paiva J.A., Popescu G.A., Serban R., Litvova S., Štefkovičova M., Serdt M., Tomazin R., Alastruey-Izquierdo A., Chryssanthou E., Candida auris survey collaborative group

Detection and characterisation capability and capacity for SARS-CoV-2 variants within the EU/EEA

Monitoring - 16 Feb 2021

ECDC has mapped the detection and characterisation capability and capacity for SARS-CoV-2 variants across the EU/EEA. This is the fifth laboratory capacity survey since the beginning of the COVID-19 pandemic in December 2019.

ECDC rapid assessment of laboratory practices and needs related to COVID-19

Monitoring - 18 Jan 2021

This report assesses the current status of the EU/EEA and the UK COVID-19 laboratory response based on a short survey sent to all Member States and the UK.

Candida auris: Epidemiological situation, laboratory capacity and preparedness in the European Union and European Economic Area, January 2018 to May 2019

Jan 2020 | Euro Surveill | 25(12)

Plachouras, D., Lötsch, F., Kohlenberg, A., Monnet, D.L., Lass-Flörl, C., Muchl, R., Willinger, B., Lagrou, K., Philipova, I., Budimir, A., Hadjihannas, L., Arendrup, M.C., Märtin, P., Lyytikäinen, O., Jalava, J., Dromer, F., Kurzai, O., Vrioni, G., Kontopidou, F., Kurcz, A., Zala, J., Sigmundsdottir, G., Burns, K., Moro, M.L., Vulane, K., Valinteliene, R., Perrin, M., Scicluna, E.A., De Greeff, S., Kacelnik, O., Deptula, A., Do Rosário Rodrigues, M., Serban, R., Stefkovicová, M., Serdt, M., Alastruey-Izquierdo, A., Berciano, P.G., Byfors, S., Brown, C.